085660.KQ KOE
Chabiotech Co.,Ltd.
1W: +6.3%
1M: +1.2%
3M: -21.7%
YTD: -59.5%
1Y: -21.9%
3Y: -35.4%
5Y: -68.3%
₩8,460.00 ($6.28)
-210.00 (-2.42%)
Weekly Expected Move ±4.6%
₩7685
₩8072
₩8460
₩8848
₩9235
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$2.55T
+16.1% ▲
5Y CAGR: +14.2%
Total Liabilities
$1.74T
+17.8% ▲
5Y CAGR: +20.8%
Shareholders Equity
$304.6B
+7.0% ▲
5Y CAGR: -3.0%
Cash & Investments
$338.7B
-4.2% ▼
5Y CAGR: -0.7%
Total Debt
$830.6B
+0.6% ▲
5Y CAGR: +22.1%
Net Debt
$593.0B
+0.4% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $122.5B | $66.6B | $60.7B | $235.4B | $237.6B |
| Short-Term Investments | $221.0B | $184.0B | $161.1B | $118.1B | $101.1B |
| Cash & ST Investments | $343.5B | $250.6B | $221.8B | $353.5B | $338.7B |
| Net Receivables | $174.8B | $211.4B | $256.3B | $289.4B | $436.4B |
| Inventory | $25.1B | $32.8B | $34.1B | $40.3B | $59.6B |
| Other Current Assets | $171.4B | $577M | $2.5B | $12.9B | $20.9B |
| Total Current Assets | $576.9B | $520.3B | $538.2B | $733.8B | $888.1B |
| Property, Plant & Equip. | $672.1B | $805.0B | $853.5B | $1.03T | $1.18T |
| Goodwill & Intangibles | $53.0B | $83.5B | $73.0B | $215.9B | $226.8B |
| Long-Term Investments | $205.9B | $167.8B | $127.1B | -$16.2B | $190.6B |
| Other Non-Current Assets | $23.0B | $25.0B | $133.8B | $224.9B | $60.2B |
| Total Non-Current Assets | $958.2B | $1.09T | $1.19T | $1.46T | $1.66T |
| Total Assets | $1.54T | $1.61T | $1.73T | $2.19T | $2.55T |
| — Liabilities — | |||||
| Accounts Payable | $44.5B | $71.7B | $80.3B | $85.1B | $57.6B |
| Short-Term Debt | $95.5B | $59.3B | $300.2B | $529.0B | $606.0B |
| Deferred Revenue | $34.6B | $14.6B | $0 | $0 | $9.8B |
| Other Current Liabilities | $106.8B | $151.4B | $88.6B | $184.6B | $644.6B |
| Total Current Liabilities | $421.5B | $477.7B | $646.2B | $1.02T | $1.32T |
| Long-Term Debt | $205.2B | $294.5B | $95.1B | $223.0B | $159.9B |
| Other Non-Current Liab. | $89.3B | $115.7B | $254.7B | $146.7B | $157.3B |
| Total Non-Current Liabilities | $320.5B | $477.3B | $423.1B | $454.9B | $415.1B |
| Total Liabilities | $742.0B | $955.1B | $1.07T | $1.48T | $1.74T |
| — Equity — | |||||
| Common Stock | $28.1B | $28.1B | $28.2B | $28.2B | $39.7B |
| Retained Earnings | $83.7B | $38.2B | $28.3B | $20.7B | $164.8B |
| Accumulated OCI | -$13.6B | -$133.8B | $0 | $0 | -$185.9B |
| Total Stockholders Equity | $456.1B | $291.7B | $281.3B | $284.7B | $304.6B |
| Total Liabilities & Equity | $1.54T | $1.61T | $1.73T | $2.19T | $2.55T |
| — Key Metrics — | |||||
| Total Debt | $333.8B | $400.9B | $449.6B | $825.9B | $830.6B |
| Net Debt | $211.3B | $334.3B | $388.9B | $590.5B | $593.0B |
| Total Investments | $426.9B | $351.8B | $288.2B | $101.9B | $291.8B |